Acta Endoscopica

, Volume 25, Supplement 2, pp 201–204 | Cite as

Ulcère duodénal: A l’ouest, y-avait-il du nouveau?

  • J. L. Friguet


— La maladie ulcéreuse duodénale est bien multifactorielle (infestation par Helicobacter pylori, hyperacidité, déficit de la production des facteurs de cytoprotection).

Des tests simples pourraient en permettre l’approche diagnostique (Breath test, UAO).

— L’épidémiologie de la maladie ulcéreuse n’est pas strictement superposable à celle d’Helicobacter pylori.

— L’approche du meilleur schéma d’éradication d’Helicobacter pylori semble se préciser: trithérapie, une semaine?

— L’oméprazole affirme sa supériorité dans toutes les situations (complications, prévention des récidives); mais il existe d’autres IPP candidats.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    RAPIER R.C., KOSS M.A., DREILINGER A.D., NYBERG L.M., PRATHA V.S., HOGAN D.L., ISENBERG J.I. — The effect of gastric metaplasia of the duodenal bulb on proximal mucosal bicarbonate secretion.University of California, San Diego (276)Google Scholar
  2. 2.
    WYETH J.W., POUNDER R.E., SMELL C.C.L. — Decrease of intragastric acidity following low doses of ranitidine.Royal Free Hospital School of Medicine, London (239)Google Scholar
  3. 3.
    MELCHERS K., WEITZENEGGER Th., STEINHILBER W., SACHS G., SCHAFER K.P. — A novel P type atepase cloned from Helicobacter pylori.Byk Gulden, Konstanz and UCLA/Wassworth/V.A. (881)Google Scholar
  4. 4.
    MERTZ-NIELSEN A., HILLINGO J., BUKHAVE K., RAYK-MADSEN J. — Helicobacter pylori does not influence gastroduodenal bicarbonate secretion and luminal release of prostaglandin E2 in humans. Hvidore and Herlev hospitals,University of Copenhagen (282)Google Scholar
  5. 5.
    TRACZ P., GUSTAVSSON S., URIBE A. — Cell proliferation in the gastrointestinal epithelium of patients with duodenal ulcer and Helicobacter pylori infection.Karolinska Institute Stockholm (322)Google Scholar
  6. 6.
    KONTUREK J.W., KONTUREK S.J., DOMSCHKE W. — Eradication of Helicobacter pylori restores the inhibitory effect of cholecystokin on postprandial gastrin release in duodenal ulcer patients.University of Munster (321)Google Scholar
  7. 7.
    SARKER S.A., MAHALANABIS D., BARDHAN P.K., ALAIM N.H., ZAMAN R., ISLAN S., GYR K. — Measurement of gastric acid secretion by a novel non invasive test. International Center for Diarrheal Disease Research, Bangladesh Dhakd.Basle University (236)Google Scholar
  8. 8.
    LANG K.A., SAYLOR J. — Gastrointestinal symptoms and the Gulf war syndrome.Wilford Hall Medical Center, Lackland (214)Google Scholar
  9. 9.
    DAVIES G.R., LEVINE D., RAMPTON D.S. — Duodenal ulcer (DU) in Helicobacter pylori infected patients: role of ethnicity, sex, smoking and neutrophil activation.GI Science Unit, London (350)Google Scholar
  10. 9.
    bis. Relationship between Helicobacter pylori infection and traditional risk factors in 12 months follow up of duodenal ulcer.Cooperative Study Group for Ulcer Disease, Italy (2059)Google Scholar
  11. 10.
    MOHANDAS K.M. — Is Helicobacter pylori infection a predictor of premature death in a community: a hypothesis.Tata Memorial Hospital, Bombay (1003)Google Scholar
  12. 11.
    FULLERTON S., OFMAN F., SOLL A.H. — Empiric antibiotic therapy vs early endoscopy in dyspeptic patients with positive serologic test for Helicobacter pylori: a decision analysis.Cure V.A. UCLA Los Angeles (201)Google Scholar
  13. 12.
    HALTER F., BRIGNOLI R. and the II Study Group Baar — Epidemiology of dyspepsia: discriminant value of smoking and helicobacter pylori status as predictors of peptic lesions in primary care. Switzerland (202)Google Scholar
  14. 13.
    WONG B.C.Y., CHING CK, LAM S.K., HU W.H.C., ONG L.Y., LAI C.L., CHAN C.K. — Association of Helicobacter pylori infection with hypoalbuminemia and dictary habits.Dept of Medicine, Hong Kong (998)Google Scholar
  15. 14.
    KUWAYAMA H., NAKAJIMA N., ARAKAWA Y. — Can endoscopic appearance of the stomach predict the presence of Helicobacter pylori?Nihon University School of Medicine, Tokyo (1002)Google Scholar
  16. 15.
    FAIGEL D.O., CHILDS M., FURTH E.E., GOIN J., ALAVIS A., METZ D.C. — Observations on the gold standard for the diagnosis of Helicobacter pylori gastritis — How gold is gold?University of Pensylvania (1001)Google Scholar
  17. 16.
    BAZZOLI F., ZAGARI R.M., FOSSI S., POZZATO P., SIMONI P., RODA A., RODA E. — The 13 C urea breath test for early assessment of Helicobacter pylori eradication.Cattedra di Gastroenterologia, Bologna (961)Google Scholar
  18. 17.
    COMBS M.J., STUBBS J.B., BUCK D.A., MARSHALL B.J. — Safety and reproducibility of the 14 C urea breath test.University of Virginia, Charlottesville (974)Google Scholar
  19. 18.
    MIVATI H.J., KOHLI Y., ITO Y., AZUMA T., KATO T.,et al — Urease probe method for endoscopic diagnosis of Helicobacter pylori infection.Fukui Medical School, Okayama (950)Google Scholar
  20. 18.
    bis. DOMINGUEZ-MUNOZ J.F., LINKE A., SAVERBRACH T., MALFERTHEINER P. — How to improve the 13 C urea breath test (UBT) for the diagnosis of Helicobacter pylori infection? Dept of Internal Medicine,University of Bonn (1583)Google Scholar
  21. 19.
    LIPSCOMB G.R., WALLIS M., AMSTRONG G., GOODMAN M.J., REES W. — Helicobacter pylori does not influence gastric mucosal adaptation to NSAIDS in man.University of Manchester (921)Google Scholar
  22. 20.
    WALTER R.S., WU S., SRIVASTAVA A.K., VANAGUNAS A.V. — Symptomatic upper gastrointestinal lesions rarely cause hemoccult positive stool.Northwestern University Medical Center — Chicago II (195)Google Scholar
  23. 21.
    BAMPTON P.A., HOLLOWAY R.H., Iron deficiency anemia in a general hospital: are upper and lower gastrointestinal investigations both necessary?Royal Adelaide Hospital (197)Google Scholar
  24. 22.
    HUSSAIN J., FAVRAR W.H., SOFIAN E.J., BADER T.F., STROM J.D., RECTOR Jr W.G. — A cost effective strategy for managing GI bleeding secondary to peptic ulcer disease.Kaiser Permanente Denver Co. (1557)Google Scholar
  25. 22.
    bis. LANS S., SUNG J.Y., LAN J.F.T., CHAN A.C.W., NY E.K.W., CHUNG S.C.S. — Stigmata of recent hemorrhage in peptic ulcer bleeding: is there inter observer agreement among international experts? Prince of Wales Hospital —The Chinese University of Hong-Kong (1703)Google Scholar
  26. 23.
    GRAMELK J.M., JENSEN D.M., JENSEN M.E., CHENG, J. GORNHEIM S. and the cure hemostasis Research Group — Assessment of direct costs for hospitalized patients with non-bleeding visible vessel treated with medical — surgical therapy or endoscopic hemostasis in a randomized controlled trial.Los Angeles (1558)Google Scholar
  27. 23.
    bis. GRAMELK M., JENSEN D.M., JENSEN M.E., CHENG S., GORNHEIM J. and the cure hemostasis Research Group — Assessment of direct costs for hospitalized patients with active ulcer hemorrhage treated with medical — surgical therapy or endoscopic hemostasis in a randomized controlled trial.Los Angeles (1702)Google Scholar
  28. 24.
    SCHAFFALITZKY de MUCKADELL O.B., HAVLELUND T., HARLING H., BOESBY S., SNEL P., UREEBURG E.N., ERIKSSON S., FENSTROM P., HASSELGREN G. — Omeprazole improves outcome in peptic ulcer bleeding.Odense University Hospital, DK (1559)Google Scholar
  29. 25.
    LIND T., AALAND E., ERIKSSON S., FENSTROM P., HASSELGREN G., LUNDER L. — Beneficial effects of IV omeprazole in patients with peptic ulcer bleeding.Odense University Hospital, DK (1560)Google Scholar
  30. 26.
    STEIN C., LAINE L. — Randomized comparison of normal saline injection vs bipolar electrocoagulation in high-risk patients with bleeding ulcers.USC School of Medicine, Los Angeles (1827)Google Scholar
  31. 27.
    JENSEN D.M., KOVACS T.O.G., JUTABHA R., RANDALL G.M., CHENG S., JENSEN M.E., FREEMAN M., GRALNEKI M., SUE M., MACHICADO G.A., GORNBEIN J. — Final results and cost assessment of endoscopy vs medical therapies for prevention of recurrent ulcer hemorrhages from adherent clots in a randomized controlled trial. (1828)Google Scholar
  32. 28.
    CHALMERS T.C., ROSS S.D., NEILL G., LAN J., KUPELNICK B., WHITING G. — A year after the NIH consensus statement on eradication of Helicobacter pylori in peptic ulcer disease, how best to do it?New England Medical Center Boston Mass, Astra Merck Group, Wayne Pa. (198)Google Scholar
  33. 29.
    DELCHIER J.C., ELAMINE I., GOLDAIN D., CHAUSSADE S., MANCINI L., IDSTROM J.C. — Comparison of omeprazole + Amoxicillin vs omeprazole + Amoxicillin + Clarithromycin in the eradication of Helicobacter pylori. Results from a randomized study involving 120 patients.Centre Hospitalier H. Mondor, Créteil, Astra Hassle (2596)Google Scholar
  34. 29.
    bis. BUCKLEY M., KEATING S., XIA H., BEATTIE S., HAMILTON H., MORAIN C.O. — Omeprazole plus one or two antibiotics to eradicate Helicobacter pylori.Adelaide Hospital, Dublin (2131)Google Scholar
  35. 30.
    SALDUIN S., BATTAGLIA G., DAL BO M., LECIS P.E., PILOTTO A., FERRANA M., VIANELLO F., KUSSTACHER S., DI MARIO F. — Clarithromycine for the cure of Helicobacter pylori infection: one or two weeks of treatment?Dept of gastroenterology of Padua and Venice (2121)Google Scholar
  36. 31.
    YOUFSI M. M., ELZIMALTY H.N.T., ASSI AL, COLE R.A., GENTA R.H., GRAHAM D.Y. — Metronidazole, omeprazole and Clarithromycin (MOC): an effective combination therapy for Helicobacter pylori infection.V.A. Medical Center, Houston (2115)Google Scholar
  37. 32.
    BARDHAN K.D., CHRIAN P., VAISHNAVI A., JONES R.B., MORRIS P., THOMPSON M., BROOKS A., SILVA J.D., GILLON K.R.W., PARKIN S.A., PATTERSON J. — « High risk » duodenal ulcer: long term maintenance treatment with low (10 mg) and pull (20 mg) dose omeprazole vs ranitidine.Rothernam General Hospital, UK (3125)Google Scholar
  38. 33.
    SUE S.O., MURDOCH R.H., SULLMAN J.A., KLEOODIS C. — Ranitidine in the prevention of NSAID-Associated ulcers in patients with arthritis.Gastro Research Institute — Research Triangle Park MC. (3113)Google Scholar

Copyright information

© Springer-Verlag 1995

Authors and Affiliations

  • J. L. Friguet
    • 1
  1. 1.Rennes

Personalised recommendations